Chinese biotech-focused SPAC GRD Biotechnology Acquisition seeks $40m in US IPO

Chinese biotech-focused SPAC GRD Biotechnology Acquisition seeks $40m in US IPO

Photo by national cancer institute XknuBmnjbKg on Unsplash

Khamila Mulia

28 July, 2023

Edited by: Pramod Mathew

biotechSPAC

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.